Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Holl

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Carbohydrate Research|August 29, 2012
Design and stereoselective synthesis of a C-aryl furanoside as a conformationally constrained CHIR-090 analogueAlberto Oddo, Ralph Holl
Current Topics in Medicinal Chemistry|April 14, 2016
Insights into the Zinc-Dependent Deacetylase LpxC: Biochemical Properties and Inhibitor DesignDmitrii V Kalinin, Ralph Holl
Expert Opinion on Therapeutic Patents|July 26, 2017
LpxC inhibitors: a patent review (2010-2016)Dmitrii V Kalinin, Ralph Holl
European Journal of Medicinal Chemistry|February 12, 2016
Chiral pool synthesis and biological evaluation of C-furanosidic and acyclic LpxC inhibitorsHannes Müller, Valeria Gabrielli, Oriana Agoglitta, et al.
Carbohydrate Research|October 3, 2012
Stereocontrolled synthesis of four diastereomeric C-aryl manno- and talofuranosidesElisa Ravarino, Sunit Kumar Jana, Roland Fröhlich, et al.
Bioorganic & Medicinal Chemistry|December 17, 2008
Relationships between the structure of 6-allyl-6,8-diazabicyclo[3.2.2]nonane derivatives and their sigma receptor affinity and cytotoxic activityRalph Holl, Dirk Schepmann, Renate Grünert, et al.
Bioorganic & Medicinal Chemistry|February 7, 2009
Relationships between the structure of 6-substituted 6,8-diazabicyclo[3.2.2]nonan-2-ones and their sigma receptor affinity and cytotoxic activityRalph Holl, Dirk Schepmann, Patrick J Bednarski, et al.
Central Nervous System Agents in Medicinal Chemistry|December 22, 2009
Structure-affinity-relationship study of bicyclic sigma receptor ligandsRalph Holl, Christian Geiger, Masakazu Nambo, et al.
Journal of Medicinal Chemistry|February 27, 2009
Dancing of the second aromatic residue around the 6,8-diazabicyclo[3.2.2]nonane framework: influence on sigma receptor affinity and cytotoxicityRalph Holl, Dirk Schepmann, Roland Fröhlich, et al.
Bioorganic & Medicinal Chemistry|January 14, 2014
Synthesis, biological evaluation and molecular docking studies of benzyloxyacetohydroxamic acids as LpxC inhibitorsMarina Szermerski, Jelena Melesina, Kanin Wichapong, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Carbohydrate Research|August 29, 2012
Design and stereoselective synthesis of a C-aryl furanoside as a conformationally constrained CHIR-090 analogueAlberto Oddo, Ralph Holl
Current Topics in Medicinal Chemistry|April 14, 2016
Insights into the Zinc-Dependent Deacetylase LpxC: Biochemical Properties and Inhibitor DesignDmitrii V Kalinin, Ralph Holl
Expert Opinion on Therapeutic Patents|July 26, 2017
LpxC inhibitors: a patent review (2010-2016)Dmitrii V Kalinin, Ralph Holl
European Journal of Medicinal Chemistry|February 12, 2016
Chiral pool synthesis and biological evaluation of C-furanosidic and acyclic LpxC inhibitorsHannes Müller, Valeria Gabrielli, Oriana Agoglitta, et al.
Carbohydrate Research|October 3, 2012
Stereocontrolled synthesis of four diastereomeric C-aryl manno- and talofuranosidesElisa Ravarino, Sunit Kumar Jana, Roland Fröhlich, et al.
Bioorganic & Medicinal Chemistry|December 17, 2008
Relationships between the structure of 6-allyl-6,8-diazabicyclo[3.2.2]nonane derivatives and their sigma receptor affinity and cytotoxic activityRalph Holl, Dirk Schepmann, Renate Grünert, et al.
Bioorganic & Medicinal Chemistry|February 7, 2009
Relationships between the structure of 6-substituted 6,8-diazabicyclo[3.2.2]nonan-2-ones and their sigma receptor affinity and cytotoxic activityRalph Holl, Dirk Schepmann, Patrick J Bednarski, et al.
Central Nervous System Agents in Medicinal Chemistry|December 22, 2009
Structure-affinity-relationship study of bicyclic sigma receptor ligandsRalph Holl, Christian Geiger, Masakazu Nambo, et al.
Journal of Medicinal Chemistry|February 27, 2009
Dancing of the second aromatic residue around the 6,8-diazabicyclo[3.2.2]nonane framework: influence on sigma receptor affinity and cytotoxicityRalph Holl, Dirk Schepmann, Roland Fröhlich, et al.
Bioorganic & Medicinal Chemistry|January 14, 2014
Synthesis, biological evaluation and molecular docking studies of benzyloxyacetohydroxamic acids as LpxC inhibitorsMarina Szermerski, Jelena Melesina, Kanin Wichapong, et al.
Pageof 3